Related Experiment Video
Updated: Jul 6, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Saudi Heart Association Position Statement on NT-proBNP for Cardiovascular Risk Screening in Asymptomatic Adults With
Waleed AlHabeeb1, Adel Tash2, Abdullah M Abdullah Arabe3
1Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia.
Journal of the Saudi Heart Association
|March 2, 2026
Summary
N-terminal pro-B-type natriuretic peptide (NT-proBNP) screening can improve cardiovascular disease (CVD) outcomes in type 2 diabetes mellitus (T2DM) patients. The Saudi Heart Association developed an algorithm for NT-proBNP screening in asymptomatic T2DM patients to enhance early detection and management.
Area of Science:
- Cardiology
- Endocrinology
- Biomarkers
Background:
- Type 2 diabetes mellitus (T2DM) is a growing global health concern, particularly in Saudi Arabia.
- Cardiovascular disease (CVD) is the primary cause of mortality in T2DM patients.
- Elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are indicative of CVD risk in T2DM.
Purpose of the Study:
- To establish an evidence-based position statement for using NT-proBNP in CVD risk stratification for T2DM patients.
- To develop a practical screening algorithm tailored for the Saudi population.
Main Methods:
- A multidisciplinary expert panel reviewed existing evidence and guidelines.
- The panel considered local population characteristics and healthcare system factors.
- An algorithm incorporating age-adapted thresholds was proposed.
Main Results:
- NT-proBNP screening shows potential for improved CVD outcomes in T2DM.
- An algorithm was developed for asymptomatic T2DM patients to guide risk stratification.
- Age-adapted thresholds aim to optimize referral and testing efficiency.
Conclusions:
- The proposed NT-proBNP screening algorithm can enhance early identification and management of CVD risk in T2DM patients in Saudi Arabia.
- Further research and local data are needed to refine implementation.
- Clinician training is essential for effective integration into routine practice.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...